Related Experiment Video
Updated: Nov 18, 2025

Robust Differentiation of Human iPSCs into a Pure Population of Adipocytes to Study Adipocyte-Associated Disorders
Published on: February 9, 2022
Clinical manifestations associated with acute viral gastroenteritis pathogens among pediatric patients in Qatar
Manar E Abdel-Rahman1, Shilu Mathew2, Asmaa A Al Thani1
1Department of Public Health, College of Health Sciences, Qatar University, Doha, Qatar.
Insights
Rotavirus (RV) and norovirus (NoV) infections are linked to severe acute gastroenteritis (AGE) in children. RV infection showed a significantly higher likelihood of severe symptoms compared to other causes.
Area of Science:
- Pediatric Infectious Diseases
- Virology
- Clinical Epidemiology
Background:
- Acute gastroenteritis (AGE) is a major global health concern in children, primarily caused by viral pathogens.
- Disease severity in pediatric AGE varies significantly depending on the causative agent, including rotavirus (RV) and norovirus (NoV).
- Understanding the association between specific viral pathogens and clinical severity is crucial for effective management.
Purpose of the Study:
- To investigate the association between specific viral pathogens and the clinical severity of acute gastroenteritis in pediatric patients.
- To compare the severity of AGE caused by single viral infections, viral-viral coinfections, and viral-bacterial mixed infections.
Main Methods:
- A total of 901 pediatric patients with AGE were analyzed in Qatar from June 2016 to June 2018.
- Virus detection was performed using the Film Array Gastrointestinal (GI) Panel kit, and severity was assessed using the Vesikari Clinical Severity Scoring System.
- Multivariable multinomial logistic regression modeled the likelihood of viral agents in relation to AGE severity.
Main Results:
- Norovirus (NoV) and rotavirus (RV) were the most common viral agents, causing 19.2% and 18.2% of infections, respectively.
- Severe clinical illness was recorded in 82.2% of RV-infected and 75.7% of NoV-infected children.
- RV infection was significantly associated with severe symptoms (a-OR = 3.10) compared to negative samples and also showed higher odds in mixed infections.
Conclusions:
- Rotavirus (RV) infection is strongly associated with increased clinical severity in pediatric acute gastroenteritis (AGE).
- The Vesikari median score was significantly higher in RV-infected pediatrics, leading to more frequent hospitalizations.
- No reduction in RV disease severity was observed irrespective of vaccination status.
Background:
Acute gastroenteritis (AGE) remains a significant cause of diarrhea that affects children worldwide. It is usually caused by viral agents, including rotavirus (RV), norovirus (NoV), adenovirus (AdV), astrovirus (AstV), and sapovirus (SaV), and the disease severity varies accordingly. Here, we report the association of clinical severity among AGE-infected pediatrics caused by a single viral pathogen, coinfection (viral-viral), mixed infection (viral-bacterial), and AGE-negative samples.
Methods:
A total of 901 pediatric patients were admitted with AGE to the Pediatric Emergency Center of Hamad Medical Corporation in Qatar from June 2016 to June 2018. The age of the subjects ranged between 3 months and 14 years (median of 16 months). Virus antigens detection was performed by using Film Array Gastrointestinal (GI) Panel kit. AGE severity was assessed using the Vesikari Clinical Severity Scoring System. Multivariable multinomial logistic regression was used to model the five AGE viral agents' likelihood in relation to severity versus co-infection, mixed infection, and AGE-negative samples.
Results:
AGE was most common in pediatrics aged 1-3 years (median age = 1.25 years) and more frequent in males than females, with a ratio of 1:0.8. About 19.2% of the infections were caused by NoV, followed by RV (18.2%), AdV (6.5%), SaV (2.3%), and AstV (1.8%). The majority of viral agents were detected higher in mixed infection (32.1%) than coinfection (4.9%). Based on the Vesikari score system, severe clinical illness was recorded among pediatrics infected with RV (82.2%) and NoV (75.7%). Further on multivariable analysis, compared to testing negative, the odds of detecting RV was three times significantly higher in children with severe symptoms relative to those with moderate (adjusted-odds ratio [a-OR] = 3.10; 95% confidence interval [CI] = 1.82-5.28). Similar results were observed when considering RV relative to co-infection and mixed infection (a-OR = 2.59; 95% CI = 1.23-5.48 and a-OR = 2.06; 1.28-3.30, respectively). About one-third of the study sample were Qatari children with AGE (33%), whereas 35% and 32% were pediatrics from the Middle East and North Africa region, excluding Qatari and nonregions.
Conclusion:
This study underlines the association of disease severity among AGE-infected pediatrics in Qatar. The overall Vesikari median score was significantly high, followed by more frequent hospitalization among RV-infected pediatrics compared to others. There was no reduction in the disease severity among RV-infected regardless of the vaccine dose.

